We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CONE
251
DELISTED
CyrusOne Inc Common Stock
CONE
| $14.3M | 0.12% |
197,093
-293,662
| -60% | -$20.9M |
|
252
CALL
iShares Russell 2000 ETF
IWM
$81.9B
| $14.3M | 0.12% |
+100,000
| New | +$13.1M |
|
253
Jefferies Financial Group
JEF
$13.1B
| $14.3M | 0.12% |
+959,883
| New | +$12.9M |
|
254
Keurig Dr Pepper
KDP
$40.8B
| $14.2M | 0.12% |
500,024
+452,649
| +955% | +$12.3M |
|
255
Henry Schein
HSIC
$9.82B
| $14.2M | 0.12% |
+242,848
| New | +$13.6M |
|
256
Kimberly-Clark
KMB
$36.5B
| $14.1M | 0.12% |
100,097
+1,541
| +2% | +$213K |
|
257
Acadia Realty Trust
AKR
$2.84B
| $14.1M | 0.12% |
1,083,283
+466,092
| +76% | +$5.8M |
|
|
TIF
258
DELISTED
Tiffany & Co.
TIF
| $14M | 0.12% |
114,975
-127,328
| -53% | -$15.9M |
|
|
FRC
259
DELISTED
First Republic Bank
FRC
| $14M | 0.12% |
131,998
-165,320
| -56% | -$17M |
|
|
MFA
260
MFA Financial
MFA
$933M
| $14M | 0.12% |
1,402,623
+1,257,036
| +863% | +$9.73M |
|
|
TCO
261
DELISTED
Taubman Centers Inc.
TCO
| $13.9M | 0.12% |
+368,595
| New | +$15.1M |
|
262
IPG Photonics
IPGP
$3.84B
| $13.9M | 0.12% |
86,554
+57,624
| +199% | +$8.21M |
|
263
Freeport-McMoran
FCX
$97.5B
| $13.8M | 0.12% |
1,196,922
+57,903
| +5% | +$531K |
|
264
CALL
Goldman Sachs
GS
$303B
| $13.8M | 0.12% |
+70,000
| New | +$13.1M |
|
|
WMGI
265
DELISTED
Wright Medical Group Inc
WMGI
| $13.8M | 0.12% |
465,390
+221,520
| +91% | +$6.48M |
|
266
Howard Hughes
HHH
$4.03B
| $13.7M | 0.12% |
277,150
+254,732
| +1,136% | +$12.8M |
|
267
Voya Financial
VOYA
$9.19B
| $13.7M | 0.12% |
293,765
-229,661
| -44% | -$10.2M |
|
|
ACIA
268
DELISTED
Acacia Communications Inc
ACIA
| $13.5M | 0.12% |
+201,046
| New | +$13.6M |
|
|
CHX
269
DELISTED
ChampionX
CHX
| $13.4M | 0.12% |
1,373,776
+433,645
| +46% | +$3.97M |
|
270
Zimmer Biomet
ZBH
$18.4B
| $13.4M | 0.12% |
115,638
-261,275
| -69% | -$30.1M |
|
271
Generac Holdings
GNRC
$12.5B
| $13.3M | 0.12% |
109,027
+104,647
| +2,389% | +$11M |
|
272
Essential Properties Realty Trust
EPRT
$6.62B
| $13.2M | 0.11% |
+890,620
| New | +$12.3M |
|
273
BioMarin Pharmaceuticals
BMRN
$12.4B
| $13.2M | 0.11% |
106,826
-259,466
| -71% | -$25.8M |
|
274
American Financial Group
AFG
$12.1B
| $13.2M | 0.11% |
207,375
+203,353
| +5,056% | +$13.1M |
|
|
DLPH
275
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $13.1M | 0.11% |
+925,231
| New | +$10.4M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.